InClinica Expands European Presence
Maxime Stevens Appointed as Senior Vice President of Development
PHILADELPHIA (February 17, 2017) – InClinica, a global clinical CRO, announced that Maxime Stevens has been appointed Senior Vice President, Development, EMEA, representing the company’s operations in Europe, the Middle East and Africa. Based in the U.K., Stevens will be responsible for new business development, sales and marketing strategy, and market growth.
Stevens has more than 25 years of experience in executive leadership, finance and business development in the clinical research industry. Before joining InClinica, she served as a freelance management consultant, where she worked with companies of all sizes in the pharmaceutical, biological, medical device and CRO spaces.
“Maxime brings valuable experience to InClinica, strengthening our international presence,” said James Nolan, President and CEO, at InClinica. “Her extensive knowledge of the life sciences sector, business development and strategy, and global relations will be a valuable asset to our team.”
Stevens has received several honors throughout her career, including becoming an Honorary Member of the International Who’s Who of Professionals in 2013 and 2014 for her professional, academic and civic achievements.
InClinica is a global clinical contract research organization founded in 2016 after the acquisition of an existing global CRO. With a senior management team that brings more than 100 combined years of experience, InClinica works across all phases of the clinical research process and has a particular strength in first in man and phase 2 studies. InClinica is headquartered in Philadelphia with other locations in the U.K., Israel, and Malaysia/Singapore.